Data Foundry

Drug recalls 2014

Fosphenytoin Sodium Injection — Class II drug recall D-1429-2014

Terminated recall by Fresenius Kabi USA, LLC, reported 2014-07-16, distributed nationwide. Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in

Recall numberD-1429-2014
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmFresenius Kabi USA, LLC, Melrose Park, IL, United States
Recall initiated2014-05-02
Classified2014-07-09
Reported by FDA2014-07-16
Terminated2016-05-24
DistributedNationwide (US)
Quantity728,880 vials
Reason classesforeign material, specification failure
NDC63323-0403, 63323-0403-01, 63323-0403-02, 63323-0403-04, 63323-0403-10
Lot numbers02/15, 03/15, 04/14, 04/15, 05/14, 05/15, 06/14, 06/15, 07/15, 08/14, 09/14, 11/15, 12/14, 6003854, 6003855, 6003961, 6004011, 6004091, 6004092, 6004553, 6004554, 6004588, 6004589, 6005201, 6005202, 6005293, 6005294, 6005545, 6005546, 6005831, 6005832, 6005973, 6005974, 6006035, 6006036, 6006037, 6006174, 6006175, 6006176, 6006449 and 3 more

Product

Fosphenytoin Sodium Injection, USP, 500 mg PE/10 mL (50 mg PE/mL), (PE= phenytoin sodium equivalents) 10 mL Single Use Vial, Rx only, Manufactured for APP Fresenius Kabi USA, LLC Lake Zurich, IL 60047, NDC 63323-403-10

Reason for recall

Presence of Particular Matter: Potential glass delamination and consistent with glass particulates observed in sample vials.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1429-2014. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.